We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+8.7%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$117B
AUM Growth
+$10.7B
(+10%)
Cap. Flow
+$2.51B
Cap. Flow
% of AUM
2.14%
Top 10 Holdings %
Top 10 Hldgs %
45.31%
Holding
3,828
New
377
Increased
1,948
Reduced
1,225
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$499M |
| 2 |
Vanguard Total Bond Market
BND
|
+$461M |
| 3 |
Avantis International Small Cap Value ETF
AVDV
|
+$292M |
| 4 |
Avantis US Small Cap Value ETF
AVUV
|
+$289M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$336M |
| 2 |
Fidelity Total Bond ETF
FBND
|
+$135M |
| 3 |
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
|
+$82.5M |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$81.2M |
| 5 |
JPMorgan BetaBuilders US Equity ETF
BBUS
|
+$70.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.01% |
| 2 | Financials | 3.7% |
| 3 | Consumer Discretionary | 1.92% |
| 4 | Communication Services | 1.73% |
| 5 | Healthcare | 1.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EMX
3551
DELISTED
EMX Royalty
EMX
| $36.2K | ﹤0.01% |
14,367
| – | – |
|
3552
Zentalis Pharmaceuticals
ZNTL
$308M
| $35.2K | ﹤0.01% |
30,340
-206,183
| -87% | -$272K |
|
3553
Amplify Energy
AMPY
$163M
| $34.6K | ﹤0.01% |
10,799
-9,989
| -48% | -$29.7K |
|
3554
Pulmonx
LUNG
$49.4M
| $34.5K | ﹤0.01% |
13,336
-3,902
| -23% | -$15.4K |
|
3555
Verde Clean Fuels
VGAS
$20.8M
| $34.4K | ﹤0.01% |
+10,001
| New | +$34.1K |
|
|
NEWP
3556
New Pacific Metals
NEWP
$833M
| $33.4K | ﹤0.01% |
24,900
| – | – |
|
|
VXRT
3557
DELISTED
Vaxart
VXRT
| $33.1K | ﹤0.01% |
+73,225
| New | +$31.9K |
|
3558
Rackspace Technology
RXT
$1B
| $32.9K | ﹤0.01% |
25,715
+13,708
| +114% | +$17.9K |
|
3559
Tilray
TLRY
$479M
| $32.7K | ﹤0.01% |
7,880
-2,291
| -23% | -$10.4K |
|
|
RUMBW
3560
RUM Group Inc Warrant
RUMBW
$12.1M
| $32.6K | ﹤0.01% |
+10,500
| New | +$31.3K |
|
3561
Opko Health
OPK
$921M
| $32.3K | ﹤0.01% |
24,492
-3,605
| -13% | -$4.93K |
|
|
IVA
3562
Inventiva
IVA
$1.05B
| $31.9K | ﹤0.01% |
+10,000
| New | +$33.9K |
|
3563
American Resources Corp
AREC
$186M
| $31.4K | ﹤0.01% |
37,892
+15,000
| +66% | +$12K |
|
3564
Clover Health Investments
CLOV
$2.28B
| $31.1K | ﹤0.01% |
11,152
-4,977
| -31% | -$16.4K |
|
3565
PUT
Applovin
APP
$132B
| $30.9K | ﹤0.01% |
25,000
| – | – |
|
3566
American Battery Technology Co
ABAT
$301M
| $30.7K | ﹤0.01% |
18,958
+5,000
| +36% | +$6.49K |
|
3567
Cardlytics
CDLX
$21M
| $30.5K | ﹤0.01% |
1,852
| – | – |
|
|
HITI
3568
High Tide
HITI
$189M
| $30.3K | ﹤0.01% |
13,192
| – | – |
|
3569
Aemetis
AMTX
$119M
| $30.2K | ﹤0.01% |
+12,185
| New | +$20.6K |
|
3570
PUT
Meta Platforms (Facebook)
META
$1.51T
| $30.1K | ﹤0.01% |
+1,200
| New | +$742K |
|
3571
Compass Therapeutics
CMPX
$373M
| $29.9K | ﹤0.01% |
+11,484
| New | +$23.7K |
|
3572
PUT
Marvell Technology
MRVL
$174B
| $29.3K | ﹤0.01% |
+20,000
| New | +$1.25M |
|
3573
Cytosorbents Corp
CTSO
$22.6M
| $28.3K | ﹤0.01% |
22,115
-1,000
| -4% | -$1K |
|
3574
Opendoor
OPEN
$3.69B
| $28K | ﹤0.01% |
54,206
-30,536
| -36% | -$22.1K |
|
|
HIVE
3575
HIVE Digital Technologies
HIVE
$792M
| $27.5K | ﹤0.01% |
15,276
-60
| -0.4% | -$106 |
|
Similar funds
Creative Planning's Q2 2025 Portfolio in Review
As of Q2 2025, Creative Planning held 3,828 positions worth $117B, up 10% from $106B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Creative Planning's Q2 2025 filing shows 377 new, 1,948 increased, 1,225 reduced and 150 closed positions. Its largest new stake was CoreWeave: 140,135 shares worth $22.9M. The largest sale was Vanguard FTSE Developed Markets ETF, an estimated $336M.
By sector, the portfolio is most concentrated in Technology at 7% of assets, up from 6.3% a quarter earlier, followed by Financials and Consumer Discretionary.
- Creative Planning's largest Q2 2025 buy was CoreWeave: 140,135 shares worth $22.9M.
- Creative Planning added most to State Street SPDR Portfolio Developed World ex-US ETF in Q2 2025, an estimated $499M increase.
- Creative Planning's biggest Q2 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $336M.
- Creative Planning fully exited Discover Financial Services in Q2 2025, selling an estimated $12.3M.
- Creative Planning's ten largest holdings make up 45% of its $117B portfolio in Q2 2025.
- Creative Planning opened 377 new positions and closed 150 in Q2 2025.
- Creative Planning's portfolio value rose 10% quarter-over-quarter to $117B.
Based on Creative Planning's 13F filing for Q2 2025, filed 8 Aug 2025.